ICU superbug study reveals resistance patterns

NCT ID NCT07172932

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study looked at 314 ICU patients with bloodstream infections caused by Enterobacterales bacteria. Researchers identified how often these bacteria were resistant to common antibiotics and what patient factors increased the risk. The goal was to understand resistance patterns to help guide better treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better identify and manage antibiotic-resistant infections in ICU patients, potentially reducing deaths.

What could go wrong

This is a completed observational study, not a treatment trial. It only identifies risk factors and resistance patterns, so it cannot directly improve patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTENSIVE CARE (ICU) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis Enterobacteriaceae Infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Çankaya, Ankara, 06800, Turkey (Türkiye)